TrialDrug design, development and therapy2025
Dexmedetomidine Cannot Attenuate Liver Injury and Improve Outcomes Following Laparoscopic Living Donor Hepatectomy: A Randomised Controlled Trial.
Ling-Li Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.